[Skip to Content]
[Skip to Content Landing]
Views 621
Citations 0
Comment & Response
December 20, 2016

Evaluating a Value-Driven Outcomes Program

Author Affiliations
  • 1Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire
JAMA. 2016;316(23):2548-2549. doi:10.1001/jama.2016.17827

To the Editor In the absence of a randomized clinical trial, evaluating underlying market trends and risk is critical to determining whether an intervention resulted in real improvements in quality or costs. Unfortunately, Dr Lee and colleagues1 included neither in an observational study of a value-driven outcomes program that found reduced costs and improved quality in 3 clinical projects.

First Page Preview View Large
First page PDF preview
First page PDF preview
×